A Phase I/IIa Study of PET/CT Imaging Using INR101 Injection in Healthy Male Subjects and Patients With Suspected Prostate Cancer
Phase I/II study in the management of Healthy Male Subjects and patients with suspected prostate cancer.
100 Clinical Results associated with Yunhe Pharmaceutical (Shanghai) Co., Ltd.
0 Patents (Medical) associated with Yunhe Pharmaceutical (Shanghai) Co., Ltd.
100 Deals associated with Yunhe Pharmaceutical (Shanghai) Co., Ltd.
100 Translational Medicine associated with Yunhe Pharmaceutical (Shanghai) Co., Ltd.